Abstract Number: 1593 • ACR Convergence 2026
Efficacy of Mesenchymal Stromal Cells in Anti-MDA5+ Dermatomyositis with ILD: A Single-Center Retrospective Study
Background/Purpose: Anti-MDA5 antibody-positive dermatomyositis (MDA5+DM) is a high-risk subtype of idiopathic inflammatory myopathies (IIM), frequently complicated by interstitial lung disease (ILD) and associated with an…Abstract Number: 1852 • ACR Convergence 2026
Developmental Sacral Fusion Defines a Biologically Relevant Model for Studying Pathological Ankylosis in Axial Spondyloarthritis
Background/Purpose: Pathological ankylosis is a hallmark of axial spondyloarthritis (axSpA), yet the mechanisms driving new bone formation remain incompletely understood. Structural fusion may continue despite…Abstract Number: 2049 • ACR Convergence 2026
Chi3L1, A Senescence-Linked Factor And Aging Biomarker, That Drives MSCs Dysfunction Promoting Joint Aging And OA Progression
Background/Purpose: Osteoarthritis is an age-related joint disorder characterized by the accumulation of senescent cells. Evidence suggests that these cells generate a pathological joint microenvironment that…Abstract Number: 2639 • ACR Convergence 2026
Rationale, Design, and Initial RA Results in Basket Registry Evaluating Umbilical Lining Stem Cells in Autoimmunity
Background/Purpose: Autoimmune diseases affect over 24 million Americans, yet many patients face incomplete disease control or cumulative treatment toxicity. Umbilical cord lining-derived stem cells (ULSC)…Abstract Number: 0120 • ACR Convergence 2026
Umbilical Cord Lining Stem Cells Suppress Pro-inflammatory and Upregulate Anti-inflammatory Mediators in IIM
Background/Purpose: Patients with idiopathic inflammatory myopathy (IIM) face a treatment landscape defined by incomplete disease control and cumulative immunosuppressive toxicity. Umbilical cord lining stem cells…Abstract Number: 0064 • ACR Convergence 2025
Sclerostin from marrow adipogenic precursors is essential for bone and joint homeostasis in mice
Background/Purpose: A novel mesenchymal subpopulation known as 'marrow adipogenic lineage precursors' (MALPs) has been identified, characterized by the expression of various adipocyte markers while lacking…Abstract Number: 0472 • ACR Convergence 2025
Detrimental Effects of Umbilical Cord Blood-derived Mesenchymal Stem Cells Intra-articular Injections on Pannus Invasiveness
Background/Purpose: Studies have shown that mesenchymal stem cell (MSC) infusion ameliorates arthritis in animal models. However, the first-pass effect in the lung has directed attention…Abstract Number: 0521 • ACR Convergence 2025
Umbilical cord-derived mesenchymal stem cells suppress the pathogenesis of primary Sjögren’s disease by inducing Bach2 expression
Background/Purpose: Primary Sjögren's disease (pSD) is characterized by lymphocytic infiltration of the salivary and lacrimal glands, leading to functional loss and gradually causing dry mouth…Abstract Number: 0968 • ACR Convergence 2025
Mesenchymal Stromal Cells in Systemic Sclerosis are Dysfunctional and Have a Profibrotic and Senescent Phenotype
Background/Purpose: Mesenchymal stromal cells (MSCs) are non-hematopoietic multipotent cells with immunomodulatory, proangiogenic, and antifibrotic properties. MSC functions are mediated by paracrine soluble factors and small…Abstract Number: 1141 • ACR Convergence 2025
Modulation of Inflammatory Responses by Dental Pulp Stem Cell Extracellular Vesicles in Monosodium Urate-Stimulated Macrophages
Background/Purpose: Gout is the most prevalent form of inflammatory arthritis, with rising global incidence. It results from the deposition of monosodium urate (MSU) crystals in…Abstract Number: 1784 • ACR Convergence 2025
Multimodal Preclinical Screening Of Glucocorticoid-Induced Disruption Of Bone Remodeling In Rat
Background/Purpose: Bone toxicity during drug development can arise from intended pharmacologic mechanisms or off-target effects. Standard histopathological evaluation often fails to detect early skeletal alterations,…Abstract Number: 1791 • ACR Convergence 2025
Determining the Effect of CD14 Deficiency on Osteoblastogenesis and Subchondral Bone Remodeling In Mice
Background/Purpose: Osteoarthritis (OA) is a debilitating disease affecting ~54% of US adults 75 and older. Toll-like receptor 4 (TLR4), and its co-receptor CD14, have been…Abstract Number: 0277 • ACR Convergence 2024
Mesenchymal Stem Cells Derived from Human Bone Marrow Ameliorate Monosodium Urate Crystal-induced Inflammation
Background/Purpose: Mesenchymal stem cells (MSCs) have anti-inflammatory properties and have been implicated in several inflammatory diseases. Acute gout is initiated by IL-1β produced by monosodium…Abstract Number: 0534 • ACR Convergence 2024
Patient Reported Outcomes and Disease Activity from a Phase 1 Double-Blind Randomized Clinical Trial of Allogeneic Mesenchymal Stem Cells in Early Rheumatoid Arthritis
Background/Purpose: Mesenchymal stem (stromal) cells (MSCs) constitute an emerging therapeutic strategy for several human diseases. Small non-randomized studies have shown that MSCs may be a…Abstract Number: 0861 • ACR Convergence 2024
Stem Cell Function and Capsule Tissue Composition Are Associated with Symptoms, Joint Range of Motion and Radiographic Severity in People with Knee Osteoarthritis
Background/Purpose: Osteoarthritis is a common and debilitating condition without cure. Increased OA severity is associated with lost range of motion (ROM) in the affected joint.…
